Matches in Nanopublications for { ?s ?p "[However, the efficacy of afatinib, the second-generation irreversible EGFR TKI, as the first-line treatment in lung adenocarcinoma patients with brain metastasis has yet to be evaluated.Here, we report cases of 3 patients who received afatinib alone as the first-line treatment in combination with whole-brain radiotherapy or following surgical resection of brain metastases.All 3 patients had EGFR L858R mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP1294989.RAIRxEYxquLdSbCZgqLY_k_VSwHnRweDmScIxiKVmA4oA130_assertion description "[However, the efficacy of afatinib, the second-generation irreversible EGFR TKI, as the first-line treatment in lung adenocarcinoma patients with brain metastasis has yet to be evaluated.Here, we report cases of 3 patients who received afatinib alone as the first-line treatment in combination with whole-brain radiotherapy or following surgical resection of brain metastases.All 3 patients had EGFR L858R mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294989.RAIRxEYxquLdSbCZgqLY_k_VSwHnRweDmScIxiKVmA4oA130_provenance.